E1-2. Estimated power for secondary aim #1: The sample size of 3184 for the primary outcome will be sufficient to detect a 2% absolute difference in neonatal composite morbidity between the two groups with >80% power and significance level of 5%. This represents the difference between a 6% neonatal composite morbidity rate with delayed (based on our observational cohort study) and 4% with immediate pushing.